MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, FDMT has $566,711K in assets. $61,047K in debts. $60,241K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
939.26%
Quick Ratio
939.26%
Cash Ratio
136.96%
Debt to Asset Ratio
10.77%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Marketable securities, long-term
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Operating lease liabilities, lon...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
60,241
Marketable securities
342,414
Prepaid expenses and other current assets
10,479
Total current assets
413,134
Marketable securities, long-term
111,379
Total property and equipment
36,146
Less accumulated depreciation and amortization
21,279
Property and equipment, net
14,867
Operating lease right-of-use assets, net
18,143
Other assets
9,188
Total assets
566,711
Accounts payable
11,159
Accrued and other current liabilities
26,874
Deferred revenue
360
Operating lease liabilities, current portion
5,592
Total current liabilities
43,985
Deferred revenue, net of current portion
745
Derivative liability
358
Operating lease liabilities, long-term portion
15,821
Other liabilities
138
Total liabilities
61,047
Common stock, 0.0001 par value, 300,000,000 shares authorized at december 31, 2025 and 2024 57,607,874 and 45,793,942 shares issued and outstanding at december 31, 2025 and 2024, respectively
6
Additional paid-in-capital
1,221,235
Accumulated other comprehensive gain
727
Accumulated deficit
-716,304
Total stockholders' equity
505,664
Total liabilities and stockholders' equity
566,711
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$342,414K Cash and cashequivalents$60,241K Prepaid expenses andother current assets$10,479K Total property andequipment$36,146K Total current assets$413,134K Marketable securities,long-term$111,379K Operating leaseright-of-use assets, net$18,143K Property and equipment,net$14,867K Other assets$9,188K Less accumulateddepreciation and...$21,279K Total assets$566,711K Total liabilities andstockholders' equity$566,711K Total stockholders'equity$505,664K Total liabilities$61,047K Accumulated deficit-$716,304K Additionalpaid-in-capital$1,221,235K Total currentliabilities$43,985K Operating leaseliabilities, long-term...$15,821K Deferred revenue, net ofcurrent portion$745K Derivative liability$358K Other liabilities$138K Accumulated othercomprehensive gain$727K Common stock, 0.0001par value,...$6K Accrued and othercurrent liabilities$26,874K Accounts payable$11,159K Operating leaseliabilities, current portion$5,592K Deferred revenue$360K

4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics, Inc. (FDMT)